Göbel, Carl H. http://orcid.org/0000-0002-4283-6936
Heinze, Axel http://orcid.org/0009-0001-7780-4301
Cirkel, Anna http://orcid.org/0000-0001-8637-9637
Göbel, Hartmut http://orcid.org/0000-0003-2163-112X
Article History
Received: 12 May 2024
Accepted: 3 June 2024
First Online: 17 June 2024
Declarations
:
: Carl Göbel has received research and/or consulting funding from Novartis and Teva. Axel Heinze has received research and/or consulting funding from Novartis and Teva. Anna Cirkel declares no conflicts of interest. Hartmut Göbel has received research and/or consulting funding from Amgen, Abbvie, Allergan, Biohaven, Elli Lilly, Hormosan, Lundbeck, Novartis, Organon, Teva.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.